Skip to Main Content

WASHINGTON — RetireSafe, a Washington-based advocacy group with ties to the drug industry, appears to be behind a deluge of comments on HHS’ controversial proposal to end the current system of rebates used to negotiate the price of drugs.

Roughly 18,000 comments have been submitted about the proposal, a number that far exceeds the normal submission rate for recent Trump administration drug pricing proposals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!